FindTrial
Sign In

Evaluation of the real-world effectiveness for Chinese medication in treating patients with COVID-19

Development of Real-World Evidence for Traditional Medicine Treating COVID-19 Infection Using Novel Integrated Methods

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200006371
Enrollment
Unknown
Registered
2022-07-21
Start date
2022-08-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Western Medicine:Routine care+western medicine
Traditional Chinese Medicine:???

Sponsors

China Center for Evidence Based Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The data of confirmed cases of new coronary pneumonia, and the diagnosis and treatment data of adult patients with complete records of the main treatment plan and at least one outcome indicator will be included.

Exclusion criteria

Exclusion criteria: The data judged by the researchers to have data quality or data security issues will be excluded.

Design outcomes

Primary

MeasureTime frame
Time to symptom resolution;—

Secondary

MeasureTime frame
Time to viral clearance;Mortality;mechanical ventilation;—

Countries

CHINA

Contacts

Public ContactLiu Jie\Shi Qiuling

China Academy of Chinese Medical Sciences

dr.liujie@163.com13718716339\18290585397

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026